251 related articles for article (PubMed ID: 11049992)
21. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B.
Sylla BS; Murphy K; Cahir-McFarland E; Lane WS; Mosialos G; Kieff E
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7470-5. PubMed ID: 10852966
[TBL] [Abstract][Full Text] [Related]
22. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
[TBL] [Abstract][Full Text] [Related]
24. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG
PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374
[TBL] [Abstract][Full Text] [Related]
25. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female.
Woon ST; Ameratunga R; Croxson M; Taylor G; Neas K; Edkins E; Browett P; Gane E; Munn S
Scand J Immunol; 2008 Aug; 68(2):153-8. PubMed ID: 18702745
[TBL] [Abstract][Full Text] [Related]
26. [Clinical and gene research of X-linked lymphoproliferative disease in a Chinese family].
Zhu DX; Du J; Lan HK; Yu L; Feng ZC
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):244-8. PubMed ID: 17425868
[TBL] [Abstract][Full Text] [Related]
27. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
28. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
29. Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease.
Wu C; Sayos J; Wang N; Howie D; Coyle A; Terhorst C
Immunogenetics; 2000 Aug; 51(10):805-15. PubMed ID: 10970095
[TBL] [Abstract][Full Text] [Related]
30. X-linked lymphoproliferative disease: three atypical cases.
Nistala K; Gilmour KC; Cranston T; Davies EG; Goldblatt D; Gaspar HB; Jones AM
Clin Exp Immunol; 2001 Oct; 126(1):126-30. PubMed ID: 11678908
[TBL] [Abstract][Full Text] [Related]
31. Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus.
Palendira U; Low C; Bell AI; Ma CS; Abbott RJ; Phan TG; Riminton DS; Choo S; Smart JM; Lougaris V; Giliani S; Buckley RH; Grimbacher B; Alvaro F; Klion AD; Nichols KE; Adelstein S; Rickinson AB; Tangye SG
J Exp Med; 2012 May; 209(5):913-24. PubMed ID: 22493517
[TBL] [Abstract][Full Text] [Related]
32. Large deletion of the X-linked lymphoproliferative disease gene detected by fluorescence in situ hybridization.
Honda K; Kanegane H; Eguchi M; Kimura H; Morishima T; Masaki K; Tosato G; Miyawaki T; Ishii E
Am J Hematol; 2000 Jun; 64(2):128-32. PubMed ID: 10814994
[TBL] [Abstract][Full Text] [Related]
33. [X-chromosome recessive lymphoproliferative disease (XLP): molecular genetic studies].
Schuster V; Grimm T; Kress W; Seidenspinner S; Belohradsky BH; Müller P; Kreth HW
Klin Padiatr; 1995; 207(5):271-6. PubMed ID: 7500602
[TBL] [Abstract][Full Text] [Related]
34. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome.
Nichols KE; Harkin DP; Levitz S; Krainer M; Kolquist KA; Genovese C; Bernard A; Ferguson M; Zuo L; Snyder E; Buckler AJ; Wise C; Ashley J; Lovett M; Valentine MB; Look AT; Gerald W; Housman DE; Haber DA
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13765-70. PubMed ID: 9811875
[TBL] [Abstract][Full Text] [Related]
35. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.
Sun J; Ying W; Liu D; Hui X; Yu Y; Wang J; Wang X
Scand J Immunol; 2013 Nov; 78(5):463-7. PubMed ID: 23944711
[TBL] [Abstract][Full Text] [Related]
36. XLP: one gene, many players.
Czar MJ; Schwartzberg PL
Clin Immunol; 2001 Jul; 100(1):2-3. PubMed ID: 11414739
[No Abstract] [Full Text] [Related]
37. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
[TBL] [Abstract][Full Text] [Related]
38. X-linked lymphoproliferative disease with a novel SH2D1A gene mutation.
Debeljak M; Podkrajsek KT; Aplenc R; Jazbec J
Pediatr Blood Cancer; 2008 Jan; 50(1):187. PubMed ID: 17455312
[No Abstract] [Full Text] [Related]
39. X-linked lymphoproliferative disease in an adult.
Hoshino T; Kanegane H; Doki N; Irisawa H; Sakura T; Nojima Y; Miyawaki S; Miyawaki T
Int J Hematol; 2005 Jul; 82(1):55-8. PubMed ID: 16105760
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
